Publication | Closed Access

A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II study

Taxane TreatmentOncologyPhase I/ii StudyMedicineBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentMulticentre Dose-escalating StudyPharmacology